| Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open … J Finke, WA Bethge, C Schmoor, HD Ottinger, M Stelljes, AR Zander, ... The lancet oncology 10 (9), 855-864, 2009 | 788 | 2009 |
| Translational regulation mechanisms of AP-1 proteins PW Vesely, PB Staber, G Hoefler, L Kenner Mutation Research/Reviews in Mutation Research 682 (1), 7-12, 2009 | 289 | 2009 |
| DNMT3A mutations promote anthracycline resistance in acute myeloid leukemia via impaired nucleosome remodeling OA Guryanova, K Shank, B Spitzer, L Luciani, RP Koche, ... Nature medicine 22 (12), 1488-1495, 2016 | 240 | 2016 |
| Valproate inhibition of histone deacetylase 2 affects differentiation and decreases proliferation of endometrial stromal sarcoma cells A Hrzenjak, F Moinfar, ML Kremser, B Strohmeier, PB Staber, K Zatloukal, ... Molecular cancer therapeutics 5 (9), 2203-2210, 2006 | 190 | 2006 |
| C/EBPa controls acquisition and maintenance of adult haematopoietic stem cell quiescence M Ye, H Zhang, G Amabile, H Yang, PB Staber, P Zhang, E Levantini, ... Nature cell biology 15 (4), 385-394, 2013 | 180 | 2013 |
| Image-based ex-vivo drug screening for patients with aggressive haematological malignancies: interim results from a single-arm, open-label, pilot study B Snijder, GI Vladimer, N Krall, K Miura, AS Schmolke, C Kornauth, ... The Lancet Haematology 4 (12), e595-e606, 2017 | 169 | 2017 |
| Sustained PU. 1 levels balance cell-cycle regulators to prevent exhaustion of adult hematopoietic stem cells PB Staber, P Zhang, M Ye, RS Welner, C Nombela-Arrieta, C Bach, ... Molecular cell 49 (5), 934-946, 2013 | 160 | 2013 |
| Aggressive B-cell lymphomas in patients with myelofibrosis receiving JAK1/2 inhibitor therapy E Porpaczy, S Tripolt, A Hoelbl-Kovacic, B Gisslinger, Z Bago-Horvath, ... Blood, The Journal of the American Society of Hematology 132 (7), 694-706, 2018 | 152 | 2018 |
| Sox4 is a key oncogenic target in C/EBPα mutant acute myeloid leukemia H Zhang, M Alberich-Jorda, G Amabile, H Yang, PB Staber, A Di Ruscio, ... Cancer cell 24 (5), 575-588, 2013 | 141 | 2013 |
| PDGFR blockade is a rational and effective therapy for NPM-ALK–driven lymphomas D Laimer, H Dolznig, K Kollmann, PW Vesely, M Schlederer, O Merkel, ... Nature medicine 18 (11), 1699-1704, 2012 | 141 | 2012 |
| Waldenström’s macroglobulinaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up E Kastritis, V Leblond, MA Dimopoulos, E Kimby, P Staber, MJ Kersten, ... Annals of Oncology 29, iv41-iv50, 2018 | 125* | 2018 |
| Hematopoietic differentiation is required for initiation of acute myeloid leukemia M Ye, H Zhang, H Yang, R Koche, PB Staber, M Cusan, E Levantini, ... Cell stem cell 17 (5), 611-623, 2015 | 124 | 2015 |
| The oncoprotein NPM-ALK of anaplastic large-cell lymphoma induces JUNB transcription via ERK1/2 and JunB translation via mTOR signaling PB Staber, P Vesely, N Haq, RG Ott, K Funato, I Bambach, C Fuchs, ... Blood, The Journal of the American Society of Hematology 110 (9), 3374-3383, 2007 | 123 | 2007 |
| Two transforming C-RAF germ-line mutations identified in patients with therapy-related acute myeloid leukemia A Zebisch, PB Staber, A Delavar, C Bodner, K Hiden, K Fischereder, ... Cancer research 66 (7), 3401-3408, 2006 | 116 | 2006 |
| Common alterations in gene expression and increased proliferation in recurrent acute myeloid leukemia PB Staber, W Linkesch, D Zauner, C Beham-Schmid, C Guelly, S Schauer, ... Oncogene 23 (4), 894-904, 2004 | 115 | 2004 |
| Romidepsin plus CHOP versus CHOP in patients with previously untreated peripheral T-cell lymphoma: results of the Ro-CHOP phase III study (conducted by LYSA) E Bachy, V Camus, C Thieblemont, D Sibon, RO Casasnovas, L Ysebaert, ... Journal of Clinical Oncology 40 (3), 242-251, 2022 | 104 | 2022 |
| MALT lymphoma and extranodal diffuse large B-cell lymphoma are targeted by aberrant somatic hypermutation AJA Deutsch, A Aigelsreiter, PB Staber, A Beham, W Linkesch, C Guelly, ... Blood 109 (8), 3500-3504, 2007 | 99 | 2007 |
| Consensus criteria for diagnosis, staging, and treatment response assessment of T-cell prolymphocytic leukemia PB Staber, M Herling, M Bellido, ED Jacobsen, MS Davids, TM Kadia, ... Blood, The Journal of the American Society of Hematology 134 (14), 1132-1143, 2019 | 97 | 2019 |
| First-line venetoclax combinations in chronic lymphocytic leukemia B Eichhorst, CU Niemann, AP Kater, M Fürstenau, J Von Tresckow, ... New England Journal of Medicine 388 (19), 1739-1754, 2023 | 94 | 2023 |
| Functional precision medicine provides clinical benefit in advanced aggressive hematologic cancers and identifies exceptional responders C Kornauth, T Pemovska, GI Vladimer, G Bayer, M Bergmann, S Eder, ... Cancer discovery 12 (2), 372-387, 2022 | 86 | 2022 |
